INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Piramal Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543635	ISIN Demat INE0DK501011	Book Value 52.95	NSE Symbol PPLPHARMA	Dividend Yield (%) 0.07	Market Cap (₹ Cr.) 27,648.48	P/E 40.26	EPS 5.18	Face Value 10

Particulars (₹ Cr)	Mar 2025	Dec 2024	Sep 2024	Jun 2024

Gross Sales/Income from operations	1689.8	1248.32	1284.39	1063.2
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	1,689.80	1,248.32	1,284.39	1,063.20
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	1,689.80	1,248.32	1,284.39	1,063.20
Total Expenses	1,334.39	1,084.44	1,085.11	963.42
Cost of Sales	722.97	531.52	541.62	449.85
Employee Cost	198.96	173.55	176.72	186.96
Depreciation, amortization and depletion expense	61.17	55.46	53.61	51.85
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	351.29	323.91	313.16	274.76
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	355.41	163.88	199.28	99.78
Other Income	39.51	24.70	106.38	36.76
Profit from ordinary activities before finance costs and exceptional items	394.92	188.58	305.66	136.54
Finance Costs	30.56	29.17	29.95	24.88
Profit from ordinary activities after finance costs but before exceptional items	364.36	159.41	275.71	111.66
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	364.36	159.41	275.71	111.66
Total Tax	87.09	40.61	65.65	26.39
Net profit from Ordinary Activities After Tax	277.27	118.80	210.06	85.27
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	277.27	118.80	210.06	85.27
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	277.27	118.80	210.06	85.27
Other Comprehensive Income	13.43	-3.53	-1.10	-3.30
Total Comprehensive Income	290.70	115.27	208.96	81.97
Equity	1,324.35	1,323.58	1,323.14	1,322.95
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	2.09	0.90	1.59	0.64
EPS before Exceptional/Extraordinary items-Diluted	2.09	0.90	1.59	0.64
EPS after Exceptional/Extraordinary items-Basic	2.09	0.90	1.59	0.64
EPS after Exceptional/Extraordinary items-Diluted	2.09	0.90	1.59	0.64
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00